AMC's Turnaround Is Real. Its Stock Price Is Running Away From It.

# AMC's Turnaround Is Real. Its Stock Price Is Running Away From It.

Let's get the obvious thing out of the way: AMC has been up 84% over the last 90 days and 37% in the last 30. The stock is hovering around $2.97 with a beta sitting comfortably in the low-twos. If you own it, you're likely grinning. If you don't, you're probably wondering whether you've missed something.

You haven't missed everything. But you may have missed the point.

Here's the thing the momentum crowd isn't telling you: the fundamentals that are supposedly driving this run are genuinely good, and the market is treating them like a footnote while the tape does all the talking.

What Actually Happened

AMC reported what it called its "strongest quarter in history." Revenue jumped roughly 14%, adjusted EBITDA climbed about 70%, and free cash flow flipped positive — operating cash of roughly $107 million versus a negative $232 million a year earlier. Cash on hand nearly doubled, from about $340 million in March to roughly $778 million by June. They restructured a mountain of debt, pushing maturities out toward 2029, and paid down expensive notes.

That's not a corpse gasping for life. That's a company that stopped bleeding and started breathing again.

And yet — watch what happened to the stock. It surged on the earnings, then gave back about 11%, grinding down to around $2.20 before recovering. The fundamental story improved. The price didn't have a straight line to prove it.

So What's Moving It Now?

Be honest with yourself about what's driving the recent action, because it's not the Q2 report — that's three months old at this point.

On at least one session in late August, AMC, Cinemark, and IMAX all spiked at the same time with zero company-specific news. That's not a short squeeze in a single name. That's money rotating across theatrical exhibition as a sector, amplified by a retail following that treats a sub-$3 stock like a playground. The momentum and rotation read is far more plausible than any fresh catalyst.

The other noise is real but secondary. CEO Adam Aron publicly feuded with Robinhood over "fake equity" stock tokens — stock popped 5–8% on the spat. There's a new film distribution arm, "Leawood Films," an esports screening push, and a reported Paramount Skydance offer to guarantee roughly 30 films a year to theaters. All of it is real. None of it explains a stock that's up 84% in three months.

The Argument You Should Take Seriously

I'll make my case plainly, because hedging helps no one.

The business is genuinely on firmer ground than it's been in years. The premium-focused model works when Hollywood cooperates, box office is recovering, and the balance sheet survived. That's worth something.

But the market is pricing AMC like a meme, and the evidence suggests it's running ahead of the turnaround, not riding it.

Consider the floor. Net margin is still negative at roughly -10.6%. The 2025 net loss widened to about $632 million. Debt is still a staggering $7.9 billion. The current ratio is 0.55 and stockholders' equity is negative by about $1.4 billion. In other words: AMC is no longer drowning, but it is not debt-free, and it still needs capital-market access to keep the plumbing working.

And here's the part that keeps me up at night for a bull: management's response to every price spike is to issue equity. That's not a theory. It's the pattern across multiple raises. When the business finally becomes profitable, the people who buy the recovery get diluted by the very mechanics of the recovery. Box office strength is a derivative of Hollywood content quality; dilution is a derivative of management's discipline — and the latter has been thin.

Where I Stand

I'm not calling a top, and I'm not chasing a bottom. I'd call this a medium-conviction accumulate — but accumulate on weakness, not on momentum.

Technically, the stock cleared its 50-day support around $2.28 and sits well above its 200-day average near $1.78. RSI around 54 says neutral, not overbought — so this isn't a blow-off just yet. Short interest is a modest 5.2%, which means the squeeze upside that powered AMC in prior years is largely gone. This rally is about operational recovery, not shorts getting squeezed.

My view, with a six-month horizon:

• Bear case: ~$1.80. A content drought plus a forced raise at a dip and the dilution story reasserts itself.
• Base case: ~$2.83. Box office momentum slowly compiles into positive net margins.
• Bull case: ~$3.45. Content cooperates, debt refinances cleanly, and discipline finally shows up.

The line in the sand I'd watch: below roughly $2.10 is the invalidation. That's the raise price, and losing it means the whole setup is rolling over.

The next real catalyst is the October 20 earnings release — watch the cash-flow guidance and, more importantly, what management does with the balance-sheet flexibility they just bought themselves. Do they retire debt, or do they hand you another dilution check the moment the stock wobbles? That single question decides whether AMC's turnaround is a real turnaround or just a well-funded bounce.

The business is getting better. The question is whether the market will ever let the stock price catch up — or keep dancing ahead of it.